NAT-PREGABALIN

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 52a3fc602ad3f5d6
Drug Approval Canada Name: NAT-PREGABALIN
Product Name: NAT-PREGABALIN
Status: Marketed
Status Date: 2020-05-07
Original Market Date: 2020-05-07
Din: 02494868
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N02BF02 PREGABALIN
Atc Name: n 02 bf 02
Aig Number: 0151121002
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

PREGABALIN

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

52a3fc602ad3f5d6

Type

Standard